PANCREATIC SEROUS CYSTADENOMA RELATED MORTALITY IS ALMOST NIL. RESULTS OF A MULTINATIONAL STUDY UNDER THE AUSPICES OF THE INTERNATIONAL ASSOCIATION OF PANCREATOLOGY AND THE EUROPEAN PANCREATIC CLUB.

(1) Service De Pancréatologie Gastroentérologie, Hôpital Beaujon, Clichy, France

(2) University Of Verona Hospital Trust, Verona, Italy

(3) The Johns Hopkins Hospital, Baltimore, United States

(4) Massachusetts General Hospital, Boston, United States

(5) Asan Medical Center, Seoul, Korea, Republic Of

(6) Yamagata University Faculty Of Medicine, Yamagata, Japan

(7) Yonsei University Severance Hospital, Seoul, Korea, Republic Of

(8) Ospedali Riuniti Academic Hospital, Ancona, Italy

(9) Ospedali Riuniti Academic Hospital, Ancona, Italy

(10) The Royal Liverpool And Broadgreen University Hospitals Nhs Trust, Liverpool, United Kingdom

(11) University Of Padua, Padua, Italy

(12) S.orsola-Malpighi Hospital, Bologna, Italy

(13) San Raffaele Scientific Institute, Milano, Italy

(14) Pancreatic Unit, Clinica Pederzoli, Verona, Italy

(15) Erasme Hospital, Free University Of Brussels, Brussels, Belgium

(16) Southwest Hospital, Third Military Medical University, Chongqing, China

(17) Samsung Medical Center, Seoul, Korea, Republic Of

(18) Freeman Hospital, Newcastle, United Kingdom

(19) National Institute Of Surgery And Transplantology Named After Shalimov, Kiev, Ukraine

(20) Karolinska University Hospital, Stockholm, Sweden

(21) Brigham And Women's Hospital Harvard Medical School, Boston, United States

(22) Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil

(23) Hôpital Privé Jean Mermoz, Lyon, France

(24) Service De Pancréatologie Gastroentérologie , Hôpital Beaujon, Clichy, France



This item was part of the Cystic pancreatic lesions: A clinical dilemma session at UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)